Clinical Trial Update: Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating granulocyte colony-stimulating factor (G-CSF) for the treatment of unexplained recurrent miscarriage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: University of Florence | Conditions: Habitual Abortion | Phase 4 | Status: COMPLETED